These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 14655446)

  • 21. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
    Ballard CG; Margallo-Lana ML
    J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reader response to, "Effects of risperidone on aberrant behavior in persons with developmental disabilities: I. A double-blind crossover study using multiple measures".
    Levitas A
    Am J Ment Retard; 2003 May; 108(3):212-4; author reply 214-6. PubMed ID: 12691600
    [No Abstract]   [Full Text] [Related]  

  • 24. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 27. Impractical features of long-acting risperidone.
    Amdur MA
    Psychiatr Serv; 2004 Dec; 55(12):1443; author reply 1443-4. PubMed ID: 15572577
    [No Abstract]   [Full Text] [Related]  

  • 28. The use of antipsychotic agents in the management of behavioral disorders in the elderly with dementia: evaluating recent clinical data.
    Worz CR
    Director; 2008; 16(2):17-20. PubMed ID: 19343879
    [No Abstract]   [Full Text] [Related]  

  • 29. Risperidone treatment of behavioral disturbances in outpatients with dementia.
    Irizarry MC; Ghaemi SN; Lee-Cherry ER; Gomez-Isla T; Binetti G; Hyman BT; Growdon JH
    J Neuropsychiatry Clin Neurosci; 1999; 11(3):336-42. PubMed ID: 10440009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrovascular events after treatment of dementia patients with risperidone.
    Wancata J
    Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of risperidone among individuals with mental retardation: clinically supported or not?
    Singh AN; Matson JL; Cooper CL; Dixon D; Sturmey P
    Res Dev Disabil; 2005; 26(3):203-18. PubMed ID: 15668072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable sustained-release risperidone: recurrence of delirium and treatment failure.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131515
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
    Stoppe G; Schreiner A; Schmitt AB
    Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
    Shah A; Suh GH
    Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589
    [No Abstract]   [Full Text] [Related]  

  • 36. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Facilitating nursing at home and in the nursing home].
    Krankenpfl J; 2005; 43(1-3):34-5. PubMed ID: 15912827
    [No Abstract]   [Full Text] [Related]  

  • 38. Risperidone and late onset tics.
    Feroz-Nainar C; Roy M
    Autism; 2006 May; 10(3):302-7. PubMed ID: 16682400
    [No Abstract]   [Full Text] [Related]  

  • 39. Bradycardia at low doses of risperidone.
    Tran KT; Golden P; Lark T; Jacob NJ
    Am J Psychiatry; 2004 Dec; 161(12):2325-6. PubMed ID: 15569911
    [No Abstract]   [Full Text] [Related]  

  • 40. Establishing a dose-response relationship for oral risperidone in relapsed schizophrenia.
    Ezewuzie N; Taylor D
    J Psychopharmacol; 2006 Jan; 20(1):86-90. PubMed ID: 16174679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.